These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3021362)

  • 1. Direct demonstration of an inhibitor of sodium, potassium dependent adenosine triphosphatase (Na+, K+-ATPase) in plasma from normotensive and hypertensive subjects.
    Roulston JE; Traill K; Wathen CG
    Clin Chim Acta; 1986 Sep; 159(2):163-71. PubMed ID: 3021362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na-K-adenosine triphosphatase and cation content in the erythrocyte in essential hypertension.
    Rahman M; Koh H; Primera MI; Del Greco F; Quintanilla AP
    J Lab Clin Med; 1986 Apr; 107(4):337-41. PubMed ID: 3007645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasma inhibitor of sodium and potassium activated adenosine triphosphatase in patients with essential hypertension.
    Toriyabe S; Miura Y; Kimura S; Meguro Y; Sugawara T; Noshiro T; Takahashi M; Ohashi H; Sano N; Watanabe H
    Tohoku J Exp Med; 1988 Jun; 155(2):129-37. PubMed ID: 2850642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension.
    Gonick HC; Weiler EW; Khalil-Manesh F; Weber MA
    Am J Hypertens; 1993 Aug; 6(8):680-7. PubMed ID: 8217031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
    Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
    Canestrari F; Galli F; Gheller G; De Crescentini S; Biagiarelli B
    Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Na+ + K+) ATPase inhibitors and intracellular electrolytes in essential hypertension.
    Iwaoka T; Nugent CA; Umeda T; Sato T
    Jpn Heart J; 1987 Sep; 28(5):695-705. PubMed ID: 2828706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement by bioluminescence technique of erythrocyte membrane Na+,K+-ATPase activity in hypertensive patients.
    Lechi C; Corradini P; Polignano R; Bonadonna G; Delva P; Lechi A
    Clin Chim Acta; 1987 Mar; 163(3):329-37. PubMed ID: 3034452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.
    de Wardener HE; Millett J; Holland S; MacGregor GA; Alaghband-Zadeh J
    Hypertension; 1987 Nov; 10(5 Pt 2):I52-6. PubMed ID: 2824366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three red cell sodium transport systems in hypertensive and normotensive Utah adults.
    Smith JB; Ash KO; Hunt SC; Hentschel WM; Sprowell W; Dadone MM; Williams RR
    Hypertension; 1984; 6(2 Pt 1):159-66. PubMed ID: 6327514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN; Ogorodnikova LE; Titkov IuS
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma.
    Holland S; Millett J; Alaghband-Zadeh J; de Wardener H; Ferrari P; Bianchi G
    Hypertension; 1987 May; 9(5):498-503. PubMed ID: 3032790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Na+-K+ ATPase kinetics in a subset of essential hypertensive patients.
    de la Sierra A; Coca A; Aguilera MT; Urbano A
    Eur J Clin Invest; 1988 Aug; 18(4):337-42. PubMed ID: 2844545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic study of Na+-K+ pump in erythrocytes from essential hypertensive patients.
    Diez J; Hannaert P; Garay RP
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H1-6. PubMed ID: 3028158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase].
    Henning G; Cloix JF
    C R Seances Acad Sci III; 1983; 297(6):295-8. PubMed ID: 6318931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.